1. Home
  2. LVWR vs GYRE Comparison

LVWR vs GYRE Comparison

Compare LVWR & GYRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LiveWire Group Inc.

LVWR

LiveWire Group Inc.

HOLD

Current Price

$4.95

Market Cap

773.1M

Sector

N/A

ML Signal

HOLD

Logo Gyre Therapeutics Inc.

GYRE

Gyre Therapeutics Inc.

HOLD

Current Price

$7.68

Market Cap

755.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LVWR
GYRE
Founded
2022
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
773.1M
755.7M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
LVWR
GYRE
Price
$4.95
$7.68
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$17.00
AVG Volume (30 Days)
56.2K
61.3K
Earning Date
11-04-2025
11-07-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.04
Revenue
$25,078,000.00
$107,265,000.00
Revenue This Year
$249.13
$11.59
Revenue Next Year
$98.53
$26.31
P/E Ratio
N/A
$201.07
Revenue Growth
N/A
2.13
52 Week Low
$0.93
$6.11
52 Week High
$9.04
$14.42

Technical Indicators

Market Signals
Indicator
LVWR
GYRE
Relative Strength Index (RSI) 60.18 47.43
Support Level $3.97 $7.36
Resistance Level $4.56 $8.50
Average True Range (ATR) 0.31 0.35
MACD 0.11 0.02
Stochastic Oscillator 93.10 30.70

Price Performance

Historical Comparison
LVWR
GYRE

About LVWR LiveWire Group Inc.

LiveWire Group Inc is an all-electric vehicle company. It sells electric vehicles and related parts and accessories and apparel in the United States and certain international markets. The company's segment includes Electric Motorcycles and STACYC. Electric Motorcycles segment sells electric motorcycles, related parts and accessories and apparel in the United States and certain international markets; STACYC segment sells electric balance bikes for kids, related parts and accessories and apparel in the United States and certain international markets. LiveWire generates revenue from the sale of electric motorcycles, Parts, accessories and apparel. Majority of revenue is from USA.

About GYRE Gyre Therapeutics Inc.

Gyre Therapeutics Inc is a commercial-stage pharmaceutical company developing and commercializing small-molecule anti-inflammatory and anti-fibrotic drugs targeting organ diseases, focusing specifically on organ fibrosis. The company's commercial-stage products include ETUARY, Avatrombopag, and Nintedanib. In addition, it is focused on the development and commercialization of Hydronidone (F351) for the treatment of Metabolic Dysfunction Associated Steatohepatitis (MASH-associated liver fibrosis (MASH fibrosis). Gyre is also advancing a diverse pipeline of different drug candidates in China, including F573, F528, and F230. The company's reportable segments are Gyre Pharmaceuticals, which derives maximum revenue from the sale of ETUARY and certain generic drugs in the PRC, Gyre, and Other.

Share on Social Networks: